NCT03004339View on ClinicalTrials.gov

Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 13, 2017

Study Completion Date

February 13, 2017

Conditions

Plaque Psoriasis

Interventions

DRUG

SOR007 Ointment 2.0%

DRUG

SOR007 Ointment 1.0%

DRUG

SOR007 Ointment 0.3%

DRUG

SOR007 Ointment 0.15%

DRUG

SOR007 Ointment Placebo

DRUG

Taclonex® Ointment

Trial Locations (2)

77845

J&S Studies, Inc., College Station

78759

DermResearch, Inc., Austin

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bioskin GmbH

INDUSTRY

collaborator

US Biotest, Inc.

INDUSTRY

lead

DFB Soria, LLC

INDUSTRY

NCT03004339 - Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test | Biotech Hunter | Biotech Hunter